86. Pulmonary arterial hypertension Clinical trials / Disease details

Clinical trials : 1,181 / Drugs : 701 - (DrugBank : 126) / Drug target genes : 105 - Drug target pathways : 192

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01757808 (ClinicalTrials.gov)	August 2011	26/4/2012	A Study of Ranolazine Acute Administration and Short Term Administration in Pulmonary Arterial Hypertension	A Phase I Study of Ranolazine Acute Administration and Short Term Administration in Pulmonary Arterial Hypertension	Pulmonary Arterial Hypertension	Drug: Ranolazine;Drug: Placebo	University of Chicago	NULL	Completed	18 Years	72 Years	All	12	Phase 1	United States
2	NCT01174173 (ClinicalTrials.gov)	June 2010	23/7/2010	Ranolazine and Pulmonary Hypertension	Effects of Ranolazine in Patients With Angina Due to Right Ventricular Ischemia in Pulmonary Arterial Hypertension	Angina;Pulmonary Arterial Hypertension	Drug: Ranolazine	Northwestern University	Gilead Sciences	Completed	18 Years	80 Years	All	11	Phase 3	United States